Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Payables (2016 - 2025)

Phibro Animal Health (PAHC) has 13 years of Payables data on record, last reported at $133.3 million in Q4 2025.

  • For Q4 2025, Payables rose 34.04% year-over-year to $133.3 million; the TTM value through Dec 2025 reached $133.3 million, up 34.04%, while the annual FY2025 figure was $138.2 million, 61.51% up from the prior year.
  • Payables reached $133.3 million in Q4 2025 per PAHC's latest filing, up from $130.6 million in the prior quarter.
  • Across five years, Payables topped out at $138.2 million in Q2 2025 and bottomed at $62.8 million in Q1 2021.
  • Average Payables over 5 years is $91.7 million, with a median of $86.0 million recorded in 2023.
  • Peak YoY movement for Payables: decreased 22.74% in 2023, then soared 61.51% in 2025.
  • A 5-year view of Payables shows it stood at $80.7 million in 2021, then decreased by 0.22% to $80.5 million in 2022, then grew by 7.36% to $86.4 million in 2023, then increased by 15.09% to $99.4 million in 2024, then skyrocketed by 34.04% to $133.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Payables were $133.3 million in Q4 2025, $130.6 million in Q3 2025, and $138.2 million in Q2 2025.